Asset Allocation

As of February 28, 2026.
Type % Net
Cash 43.38%
Stock 23.58%
Bond 33.55%
Convertible 0.00%
Preferred 0.00%
Other -0.51%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 59.29%    % Emerging Markets: 0.76%    % Unidentified Markets: 39.96%

Americas 58.45%
58.15%
Canada 3.37%
United States 54.78%
0.30%
Mexico 0.19%
Peru 0.06%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 0.94%
United Kingdom 0.20%
0.39%
Ireland 0.26%
Netherlands 0.02%
Switzerland 0.10%
0.00%
0.36%
South Africa 0.36%
Greater Asia 0.65%
Japan 0.00%
0.47%
Australia 0.47%
0.03%
Singapore 0.03%
0.15%
China 0.05%
Indonesia 0.09%
Unidentified Region 39.96%

Bond Credit Quality Exposure

AAA 0.00%
AA 70.34%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 29.66%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
15.23%
Materials
11.46%
Consumer Discretionary
1.26%
Financials
1.73%
Real Estate
0.77%
Sensitive
5.85%
Communication Services
0.48%
Energy
1.60%
Industrials
2.03%
Information Technology
1.73%
Defensive
3.21%
Consumer Staples
0.88%
Health Care
1.49%
Utilities
0.84%
Not Classified
75.72%
Non Classified Equity
0.02%
Not Classified - Non Equity
75.70%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 100.00%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
78.28%
Less than 1 Year
78.28%
Intermediate
21.72%
1 to 3 Years
21.72%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial